Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Krystal Biotech Q1 2024 Earnings Preview
Why Krystal Biotech (KRYS) Might Surprise This Earnings Season
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable
Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable
Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.